Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloidosis | 3 | 2022 | 795 | 1.420 |
Why?
|
Cardiomyopathy, Dilated | 5 | 2022 | 851 | 1.160 |
Why?
|
Cardiomyopathy, Hypertrophic | 4 | 2022 | 1263 | 1.050 |
Why?
|
Calsequestrin | 2 | 2020 | 30 | 0.960 |
Why?
|
Echocardiography | 7 | 2023 | 5097 | 0.840 |
Why?
|
Artificial Intelligence | 5 | 2024 | 2187 | 0.770 |
Why?
|
Medicine | 2 | 2020 | 941 | 0.710 |
Why?
|
Stroke Volume | 8 | 2024 | 4983 | 0.680 |
Why?
|
Hematology | 1 | 2022 | 219 | 0.670 |
Why?
|
Electrocardiography | 7 | 2024 | 6440 | 0.640 |
Why?
|
Cardiomyopathies | 5 | 2022 | 1912 | 0.630 |
Why?
|
Phenotype | 10 | 2023 | 16331 | 0.590 |
Why?
|
Tachycardia, Ventricular | 3 | 2020 | 1272 | 0.580 |
Why?
|
Heart Failure | 8 | 2023 | 10856 | 0.550 |
Why?
|
Genetic Testing | 4 | 2010 | 3439 | 0.550 |
Why?
|
Pattern Recognition, Automated | 3 | 2019 | 996 | 0.530 |
Why?
|
Heart Rate | 2 | 2019 | 4091 | 0.510 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5867 | 0.490 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 719 | 0.480 |
Why?
|
Genetic Predisposition to Disease | 9 | 2023 | 17400 | 0.470 |
Why?
|
Zebrafish | 7 | 2022 | 2990 | 0.460 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2024 | 2059 | 0.440 |
Why?
|
Myocytes, Cardiac | 4 | 2018 | 1636 | 0.440 |
Why?
|
Action Potentials | 1 | 2019 | 1814 | 0.410 |
Why?
|
Connexin 43 | 1 | 2012 | 206 | 0.410 |
Why?
|
Alternative Splicing | 2 | 2016 | 1118 | 0.400 |
Why?
|
Muscular Diseases | 1 | 2015 | 557 | 0.390 |
Why?
|
Sequence Deletion | 1 | 2015 | 1526 | 0.380 |
Why?
|
Genome-Wide Association Study | 8 | 2023 | 12220 | 0.380 |
Why?
|
Heart Diseases | 1 | 2024 | 2789 | 0.380 |
Why?
|
Cardiovascular Diseases | 6 | 2022 | 15108 | 0.350 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2014 | 859 | 0.340 |
Why?
|
Hypertension | 3 | 2022 | 8455 | 0.320 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2017 | 1728 | 0.320 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1527 | 0.310 |
Why?
|
Rest | 1 | 2012 | 900 | 0.310 |
Why?
|
Calcium | 2 | 2020 | 5753 | 0.310 |
Why?
|
Myocardium | 1 | 2020 | 4775 | 0.300 |
Why?
|
Systems Biology | 1 | 2010 | 469 | 0.290 |
Why?
|
Lipoprotein(a) | 1 | 2011 | 425 | 0.290 |
Why?
|
Arrhythmias, Cardiac | 2 | 2016 | 2267 | 0.290 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2010 | 602 | 0.270 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3328 | 0.260 |
Why?
|
Ventricular Function, Left | 4 | 2024 | 3656 | 0.260 |
Why?
|
Metabolic Networks and Pathways | 1 | 2010 | 782 | 0.260 |
Why?
|
Genetic Loci | 2 | 2011 | 2572 | 0.240 |
Why?
|
Crystallography, X-Ray | 4 | 2020 | 2014 | 0.240 |
Why?
|
Semaphorin-3A | 1 | 2003 | 39 | 0.240 |
Why?
|
Metabolome | 1 | 2010 | 881 | 0.220 |
Why?
|
Humans | 59 | 2024 | 742088 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2723 | 0.220 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 11695 | 0.220 |
Why?
|
Computational Biology | 2 | 2016 | 3518 | 0.210 |
Why?
|
Triglycerides | 2 | 2014 | 2450 | 0.210 |
Why?
|
Cholesterol, HDL | 1 | 2009 | 1813 | 0.210 |
Why?
|
Genome | 1 | 2010 | 1803 | 0.210 |
Why?
|
Anthracyclines | 1 | 2024 | 288 | 0.200 |
Why?
|
Genome, Human | 3 | 2012 | 4420 | 0.200 |
Why?
|
Blood Cells | 1 | 2023 | 309 | 0.200 |
Why?
|
Markov Chains | 2 | 2019 | 969 | 0.200 |
Why?
|
RNA-Binding Proteins | 3 | 2001 | 1899 | 0.200 |
Why?
|
Genomics | 2 | 2014 | 5692 | 0.190 |
Why?
|
Mutation | 6 | 2020 | 29717 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2023 | 15494 | 0.190 |
Why?
|
Electronic Health Records | 2 | 2021 | 4440 | 0.190 |
Why?
|
Peptide Synthases | 1 | 2001 | 80 | 0.190 |
Why?
|
Disease Models, Animal | 4 | 2015 | 18006 | 0.190 |
Why?
|
Rotavirus | 1 | 2002 | 109 | 0.190 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13655 | 0.190 |
Why?
|
Viral Nonstructural Proteins | 1 | 2002 | 241 | 0.180 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 692 | 0.180 |
Why?
|
Genetic Variation | 2 | 2012 | 6540 | 0.180 |
Why?
|
Prealbumin | 1 | 2021 | 210 | 0.180 |
Why?
|
Cardiology | 2 | 2021 | 1658 | 0.170 |
Why?
|
Poly A | 1 | 1999 | 185 | 0.170 |
Why?
|
Models, Molecular | 5 | 2020 | 5454 | 0.170 |
Why?
|
Cholesterol, LDL | 1 | 2009 | 2354 | 0.170 |
Why?
|
Penetrance | 2 | 2010 | 380 | 0.160 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2021 | 138 | 0.160 |
Why?
|
Molecular Sequence Data | 9 | 2015 | 18112 | 0.160 |
Why?
|
Mutation, Missense | 2 | 2020 | 2556 | 0.160 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2019 | 93 | 0.160 |
Why?
|
Algorithms | 2 | 2015 | 13853 | 0.160 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2020 | 474 | 0.160 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15056 | 0.150 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2003 | 2837 | 0.150 |
Why?
|
Quantitative Trait Loci | 2 | 2023 | 2015 | 0.150 |
Why?
|
Glucose | 1 | 2010 | 4391 | 0.150 |
Why?
|
Genes, Dominant | 1 | 2020 | 880 | 0.150 |
Why?
|
Cell Adhesion Molecules | 1 | 2003 | 1599 | 0.150 |
Why?
|
Zebrafish Proteins | 3 | 2022 | 1004 | 0.150 |
Why?
|
Hydrogen Bonding | 3 | 2003 | 293 | 0.150 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2017 | 68 | 0.150 |
Why?
|
Phosphoproteins | 2 | 2017 | 2440 | 0.140 |
Why?
|
Cloning, Molecular | 3 | 2020 | 4322 | 0.140 |
Why?
|
Coronary Aneurysm | 1 | 2019 | 237 | 0.140 |
Why?
|
RNA, Messenger | 4 | 2015 | 13029 | 0.140 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2001 | 2552 | 0.140 |
Why?
|
Automation | 1 | 2018 | 584 | 0.140 |
Why?
|
Receptors, Cell Surface | 2 | 2013 | 2867 | 0.130 |
Why?
|
Adipocytes, White | 2 | 2017 | 89 | 0.130 |
Why?
|
Homozygote | 1 | 2020 | 1777 | 0.130 |
Why?
|
Calcium-Binding Proteins | 1 | 2020 | 1081 | 0.130 |
Why?
|
Protein Multimerization | 1 | 2020 | 971 | 0.130 |
Why?
|
Hyperlipoproteinemia Type III | 1 | 2014 | 3 | 0.130 |
Why?
|
Gene Knockout Techniques | 1 | 2018 | 808 | 0.130 |
Why?
|
Binding Sites | 2 | 2020 | 6115 | 0.130 |
Why?
|
Adipocytes | 3 | 2017 | 1182 | 0.130 |
Why?
|
Research Design | 2 | 2021 | 5979 | 0.130 |
Why?
|
Sinoatrial Node | 1 | 2015 | 101 | 0.130 |
Why?
|
Workflow | 1 | 2019 | 846 | 0.120 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 527 | 0.120 |
Why?
|
Genotype | 4 | 2018 | 12946 | 0.120 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1402 | 0.120 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2014 | 106 | 0.120 |
Why?
|
Mitochondrial Proteins | 1 | 2020 | 995 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1507 | 0.120 |
Why?
|
Data Interpretation, Statistical | 2 | 2021 | 2714 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2015 | 3585 | 0.120 |
Why?
|
Prognosis | 6 | 2021 | 29010 | 0.120 |
Why?
|
Recombinant Proteins | 2 | 2020 | 6608 | 0.120 |
Why?
|
Cell Differentiation | 3 | 2017 | 11470 | 0.120 |
Why?
|
Heterozygote | 1 | 2020 | 2790 | 0.120 |
Why?
|
Mutant Proteins | 1 | 2015 | 500 | 0.110 |
Why?
|
Models, Biological | 1 | 2010 | 9581 | 0.110 |
Why?
|
Checklist | 1 | 2020 | 830 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2019 | 19862 | 0.110 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1342 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2022 | 1368 | 0.110 |
Why?
|
Oncogenic Viruses | 1 | 2012 | 42 | 0.110 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2014 | 364 | 0.110 |
Why?
|
Lipid Metabolism | 4 | 2017 | 1887 | 0.110 |
Why?
|
Pedigree | 1 | 2020 | 4646 | 0.110 |
Why?
|
Metabolism, Inborn Errors | 1 | 2015 | 288 | 0.110 |
Why?
|
Kinetics | 1 | 2020 | 6474 | 0.110 |
Why?
|
Cluster Analysis | 4 | 2017 | 2713 | 0.110 |
Why?
|
Organogenesis | 2 | 2011 | 222 | 0.110 |
Why?
|
Parturition | 1 | 2016 | 436 | 0.110 |
Why?
|
Lipase | 1 | 2014 | 315 | 0.110 |
Why?
|
Thermogenesis | 1 | 2016 | 429 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1653 | 0.100 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1224 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2019 | 1538 | 0.100 |
Why?
|
Signal Transduction | 6 | 2017 | 23387 | 0.100 |
Why?
|
Mosaicism | 1 | 2014 | 440 | 0.100 |
Why?
|
Heart | 2 | 2018 | 4462 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2001 | 1860 | 0.100 |
Why?
|
Kringles | 1 | 2011 | 6 | 0.100 |
Why?
|
Molecular Sequence Annotation | 2 | 2011 | 527 | 0.100 |
Why?
|
Research | 1 | 2020 | 1999 | 0.100 |
Why?
|
Protein Binding | 2 | 2020 | 9387 | 0.100 |
Why?
|
Muscle Development | 1 | 2013 | 271 | 0.100 |
Why?
|
Cardiotonic Agents | 1 | 2014 | 535 | 0.100 |
Why?
|
Adipocytes, Brown | 1 | 2012 | 144 | 0.100 |
Why?
|
Animals | 19 | 2022 | 168561 | 0.100 |
Why?
|
Genetic Vectors | 1 | 2020 | 3420 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4465 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2016 | 21719 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 376 | 0.090 |
Why?
|
GABA Plasma Membrane Transport Proteins | 1 | 2010 | 30 | 0.090 |
Why?
|
Echocardiography, Doppler | 2 | 2017 | 934 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2017 | 657 | 0.090 |
Why?
|
Amino Acid Transport Systems | 1 | 2010 | 32 | 0.090 |
Why?
|
Glucose Metabolism Disorders | 1 | 2010 | 54 | 0.090 |
Why?
|
Male | 20 | 2023 | 349538 | 0.090 |
Why?
|
Gene Expression Profiling | 5 | 2015 | 9410 | 0.090 |
Why?
|
Nephrons | 1 | 2011 | 220 | 0.090 |
Why?
|
Models, Genetic | 2 | 2017 | 3493 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1431 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2015 | 3617 | 0.090 |
Why?
|
Databases, Genetic | 1 | 2016 | 1780 | 0.090 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2010 | 161 | 0.080 |
Why?
|
Middle Aged | 13 | 2022 | 213127 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5062 | 0.080 |
Why?
|
Aged | 13 | 2023 | 162944 | 0.080 |
Why?
|
Intracellular Space | 1 | 2010 | 212 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1438 | 0.080 |
Why?
|
Risk Assessment | 3 | 2022 | 23320 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3528 | 0.080 |
Why?
|
Female | 21 | 2023 | 379592 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1541 | 0.080 |
Why?
|
Transgenes | 1 | 2012 | 1009 | 0.080 |
Why?
|
Escherichia coli | 1 | 2020 | 4214 | 0.080 |
Why?
|
Amino Acid Sequence | 5 | 2011 | 13814 | 0.080 |
Why?
|
Subcutaneous Fat | 1 | 2011 | 391 | 0.080 |
Why?
|
Genealogy and Heraldry | 1 | 2007 | 28 | 0.080 |
Why?
|
Extracellular Space | 1 | 2010 | 594 | 0.080 |
Why?
|
Thrombosis | 1 | 2022 | 2966 | 0.080 |
Why?
|
Syndrome | 1 | 2014 | 3248 | 0.080 |
Why?
|
Blood | 1 | 2010 | 598 | 0.080 |
Why?
|
Risk Factors | 6 | 2022 | 72145 | 0.080 |
Why?
|
Bundle-Branch Block | 1 | 2009 | 270 | 0.080 |
Why?
|
Gene Expression | 1 | 2020 | 7790 | 0.070 |
Why?
|
Dyslipidemias | 1 | 2015 | 848 | 0.070 |
Why?
|
Coronary Vessels | 1 | 2019 | 3099 | 0.070 |
Why?
|
Transcription, Genetic | 4 | 2018 | 7721 | 0.070 |
Why?
|
Pericardium | 1 | 2011 | 667 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2699 | 0.070 |
Why?
|
Glucose Tolerance Test | 1 | 2010 | 1150 | 0.070 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2009 | 414 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2010 | 939 | 0.070 |
Why?
|
Reference Values | 1 | 2014 | 4982 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2013 | 4933 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2017 | 3278 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5304 | 0.070 |
Why?
|
Regeneration | 2 | 2013 | 1485 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2017 | 19223 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2195 | 0.070 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 3847 | 0.070 |
Why?
|
Adenine | 2 | 2002 | 936 | 0.070 |
Why?
|
Immunity | 1 | 2011 | 1011 | 0.060 |
Why?
|
Obesity | 2 | 2017 | 12705 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2009 | 1097 | 0.060 |
Why?
|
Viral Proteins | 1 | 2012 | 1899 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3306 | 0.060 |
Why?
|
COS Cells | 2 | 2003 | 1160 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 6078 | 0.060 |
Why?
|
Pluripotent Stem Cells | 1 | 2012 | 795 | 0.060 |
Why?
|
Dogs | 1 | 2009 | 3910 | 0.060 |
Why?
|
Genetic Markers | 1 | 2011 | 2633 | 0.060 |
Why?
|
Immunophilins | 1 | 2003 | 20 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3920 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7716 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2017 | 3861 | 0.060 |
Why?
|
Mice | 9 | 2017 | 81045 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1780 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6259 | 0.060 |
Why?
|
United States | 7 | 2021 | 69693 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1477 | 0.060 |
Why?
|
Demography | 1 | 2007 | 1650 | 0.050 |
Why?
|
Protein Conformation | 2 | 2001 | 4013 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2007 | 2422 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7470 | 0.050 |
Why?
|
Adult | 10 | 2020 | 213712 | 0.050 |
Why?
|
Chick Embryo | 1 | 2003 | 981 | 0.050 |
Why?
|
Cytidine | 1 | 2002 | 68 | 0.050 |
Why?
|
Chromosome Mapping | 1 | 2010 | 4742 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5100 | 0.050 |
Why?
|
Alanine | 1 | 2003 | 572 | 0.050 |
Why?
|
Consensus Sequence | 1 | 2002 | 377 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2009 | 2186 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8541 | 0.050 |
Why?
|
Ganglia, Spinal | 1 | 2003 | 517 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2013 | 2956 | 0.050 |
Why?
|
Rotavirus Infections | 1 | 2002 | 86 | 0.050 |
Why?
|
T-Box Domain Proteins | 1 | 2003 | 471 | 0.050 |
Why?
|
Guanine | 1 | 2002 | 274 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2003 | 1245 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1723 | 0.050 |
Why?
|
Dimerization | 1 | 2002 | 893 | 0.050 |
Why?
|
Disease Management | 2 | 2021 | 2450 | 0.050 |
Why?
|
Prospective Studies | 4 | 2023 | 53187 | 0.040 |
Why?
|
Therapies, Investigational | 1 | 2020 | 111 | 0.040 |
Why?
|
alpha 1-Antitrypsin | 1 | 2020 | 164 | 0.040 |
Why?
|
Poly(A)-Binding Proteins | 1 | 1999 | 36 | 0.040 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2017 | 495 | 0.040 |
Why?
|
Carbon-Carbon Ligases | 1 | 1998 | 20 | 0.040 |
Why?
|
Lipids | 1 | 2010 | 3302 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2003 | 1792 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2010 | 2896 | 0.040 |
Why?
|
Heart Atria | 2 | 2015 | 1348 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 314 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2018 | 43 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7901 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 3133 | 0.040 |
Why?
|
Transcription Factors | 2 | 2015 | 12164 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40054 | 0.040 |
Why?
|
Stem Cells | 1 | 2011 | 3563 | 0.040 |
Why?
|
Myocardial Contraction | 2 | 2015 | 1585 | 0.040 |
Why?
|
Lymphocytes | 2 | 2016 | 2614 | 0.040 |
Why?
|
Cohort Studies | 3 | 2017 | 40450 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39004 | 0.040 |
Why?
|
Threonine | 1 | 2017 | 279 | 0.040 |
Why?
|
Ion Channels | 1 | 2022 | 1056 | 0.040 |
Why?
|
Creatinine | 1 | 2022 | 1916 | 0.040 |
Why?
|
American Heart Association | 1 | 2021 | 1055 | 0.040 |
Why?
|
Mechanotransduction, Cellular | 1 | 2022 | 541 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2010 | 5019 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2020 | 676 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1999 | 1202 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2014 | 5019 | 0.030 |
Why?
|
Cell Respiration | 1 | 2016 | 200 | 0.030 |
Why?
|
Heart Ventricles | 2 | 2023 | 3801 | 0.030 |
Why?
|
Lamin Type A | 1 | 2016 | 190 | 0.030 |
Why?
|
Editorial Policies | 1 | 2020 | 451 | 0.030 |
Why?
|
Brugada Syndrome | 1 | 2016 | 97 | 0.030 |
Why?
|
Metabolomics | 2 | 2017 | 1467 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2026 | 0.030 |
Why?
|
Up-Regulation | 2 | 2017 | 4211 | 0.030 |
Why?
|
High-Density Lipoproteins, Pre-beta | 1 | 2014 | 5 | 0.030 |
Why?
|
Kidney | 1 | 2011 | 7167 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3770 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5238 | 0.030 |
Why?
|
Apolipoproteins C | 1 | 2014 | 59 | 0.030 |
Why?
|
Xanthomatosis | 1 | 2014 | 32 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2017 | 657 | 0.030 |
Why?
|
Apolipoproteins A | 1 | 2014 | 94 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2003 | 2968 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 2 | 2017 | 1625 | 0.030 |
Why?
|
Cell Line | 2 | 2010 | 15994 | 0.030 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2016 | 489 | 0.030 |
Why?
|
Cobra Cardiotoxin Proteins | 1 | 2013 | 6 | 0.030 |
Why?
|
Lipoproteins, VLDL | 1 | 2014 | 201 | 0.030 |
Why?
|
Exercise | 1 | 2010 | 5611 | 0.030 |
Why?
|
Virus Replication | 1 | 2002 | 2531 | 0.030 |
Why?
|
Embryonic Development | 1 | 1998 | 704 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3587 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2126 | 0.030 |
Why?
|
Fetal Heart | 1 | 2015 | 276 | 0.030 |
Why?
|
RNA, Viral | 1 | 2002 | 2899 | 0.030 |
Why?
|
Prevalence | 1 | 2010 | 15194 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2303 | 0.030 |
Why?
|
STAT6 Transcription Factor | 1 | 2013 | 199 | 0.030 |
Why?
|
Cold Temperature | 1 | 2016 | 774 | 0.030 |
Why?
|
Organ Specificity | 1 | 2017 | 2003 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2014 | 399 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2018 | 952 | 0.030 |
Why?
|
Subtraction Technique | 1 | 2015 | 525 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 103 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2017 | 1684 | 0.030 |
Why?
|
Polyomavirus | 1 | 2012 | 248 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2014 | 57683 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2012 | 464 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 628 | 0.020 |
Why?
|
Interleukin-13 | 1 | 2013 | 389 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2016 | 2723 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2015 | 1547 | 0.020 |
Why?
|
Lipid Metabolism Disorders | 1 | 2010 | 19 | 0.020 |
Why?
|
Mice, Nude | 1 | 2017 | 3689 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 70 | 0.020 |
Why?
|
Hepatocytes | 1 | 2017 | 1209 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 637 | 0.020 |
Why?
|
3T3 Cells | 1 | 2012 | 1101 | 0.020 |
Why?
|
Base Sequence | 2 | 2018 | 12797 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1835 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2017 | 14554 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7141 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 1989 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2001 | 3020 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3001 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2013 | 1146 | 0.020 |
Why?
|
Larva | 1 | 2011 | 517 | 0.020 |
Why?
|
Adipose Tissue, White | 1 | 2012 | 345 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6891 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2012 | 810 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 21821 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3618 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2502 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2011 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6191 | 0.020 |
Why?
|
PPAR gamma | 1 | 2012 | 493 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2011 | 433 | 0.020 |
Why?
|
Eosinophils | 1 | 2013 | 953 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2013 | 804 | 0.020 |
Why?
|
Adenoviridae | 1 | 2012 | 1096 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10248 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 2014 | 882 | 0.020 |
Why?
|
Sarcomeres | 1 | 2011 | 374 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1806 | 0.020 |
Why?
|
Tissue Donors | 1 | 2017 | 2205 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2003 | 2049 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2012 | 739 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2014 | 62966 | 0.020 |
Why?
|
Hyperplasia | 1 | 2011 | 1183 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2011 | 894 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8297 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4801 | 0.020 |
Why?
|
Chemokines | 1 | 2011 | 954 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1040 | 0.020 |
Why?
|
Exercise Test | 1 | 2014 | 2075 | 0.020 |
Why?
|
Peptide Fragments | 1 | 1999 | 5095 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8436 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1707 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2012 | 1118 | 0.020 |
Why?
|
Adipose Tissue, Brown | 1 | 2012 | 754 | 0.020 |
Why?
|
Troponin T | 1 | 2011 | 749 | 0.020 |
Why?
|
Skin Diseases | 1 | 2014 | 1065 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 1546 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1749 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12773 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 1995 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9735 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11363 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9941 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4751 | 0.020 |
Why?
|
Models, Animal | 1 | 2011 | 2170 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2382 | 0.010 |
Why?
|
Retina | 1 | 2014 | 2611 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 21596 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2016 | 2746 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4200 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2009 | 20774 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2417 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 438 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6171 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1618 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1895 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5978 | 0.010 |
Why?
|
Peptide Initiation Factors | 1 | 2001 | 56 | 0.010 |
Why?
|
Codon, Initiator | 1 | 2001 | 52 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2001 | 829 | 0.010 |
Why?
|
Mutagenesis | 1 | 2003 | 1263 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2001 | 1159 | 0.010 |
Why?
|
Exons | 1 | 2003 | 2431 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10578 | 0.010 |
Why?
|
Young Adult | 2 | 2016 | 56350 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15530 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8425 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2699 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 24913 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5892 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10472 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9639 | 0.010 |
Why?
|
Child | 1 | 2022 | 77478 | 0.010 |
Why?
|
Rabbits | 1 | 2001 | 4886 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1998 | 2335 | 0.010 |
Why?
|
Hepacivirus | 1 | 2001 | 1372 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 5180 | 0.010 |
Why?
|
Cattle | 1 | 1998 | 3923 | 0.010 |
Why?
|
Aging | 1 | 2011 | 8626 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 85649 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2003 | 4566 | 0.000 |
Why?
|
Rats | 1 | 1998 | 24265 | 0.000 |
Why?
|
Pregnancy | 1 | 1998 | 29087 | 0.000 |
Why?
|